Skip to main content
JEONJINBIO CO., LTD. logo

JEONJINBIO CO., LTD. — Investor Relations & Filings

Ticker · 110020 ISIN · KR7110020005 KO Manufacturing
Open in API
Filings indexed 371 across all filing types
Latest filing 2024-01-24 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 110020

About JEONJINBIO CO., LTD.

http://jjbious.com/01

JEONJINBIO CO., LTD. is a biotechnology company specializing in the research, development, and production of products for pest control and the mitigation of damage from nuisance animals. The company's core offerings consist of natural bio-pesticides and repellents formulated from natural materials as alternatives to conventional chemical products. Its product line includes specialized solutions for repelling birds, boars, and other animals. The company emphasizes innovation and safety, supported by its dedicated research and development center and various product certifications, including USA EPA approval for its bird repellent.

Recent filings

Filing Released Lang Actions
전환청구권행사
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the exercise of conversion rights (전환청구권행사) for convertible bonds. This action results in the issuance of new shares, which directly impacts the company's capital structure. According to the filing definitions, announcements regarding new share issues or capital changes fall under the 'SHA' category.
2024-01-24 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding a change in the contract period for a management rights transfer. This falls under the category of Major Shareholding Notification (MRQ) as it tracks significant ownership thresholds and changes in control.
2024-01-16 Korean
[기재정정]의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used to provide shareholders with information regarding upcoming general meetings (such as agenda items, director candidates, and articles of incorporation changes) to solicit their votes. This falls directly under the 'Proxy Solicitation & Information Statement' category.
2024-01-16 Korean
[기재정정]주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) for Jeonjin BioPharm Co., Ltd. It details the meeting date, agenda items (such as the appointment of directors and amendments to the articles of incorporation), and provides management reference materials for shareholders. This document is a standard proxy statement/notice for a shareholder meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2024-01-16 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a regulatory filing from a Korean company (Jeonjin BioPharm) titled 'Correction of Notice of General Meeting of Shareholders'. It details changes to the date and agenda items (specifically board member nominations and business purpose additions) for an upcoming Extraordinary General Meeting. This falls under the category of Proxy Solicitation & Information Statement (PSI) as it provides shareholders with the necessary information regarding meeting agenda changes and board appointments.
2024-01-16 Korean
[기재정정]소액공모공시서류(지분증권)
Share Issue/Capital Change Classification · 100% confidence The document is a '소액공모공시서류(지분증권) 정정신고' (Small-scale Public Offering Disclosure Document Amendment) filed by Jeonjin Bio Pharm. It details changes to the payment date and listing schedule for a previously announced private placement (third-party allocation). Since this is a formal regulatory filing regarding a capital change (share issuance) and not a standalone report publication announcement, it falls under the category of Share Issue/Capital Change.
2024-01-09 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.